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ABSTRACT 
The purpose of this study is to investigate the need to account for the presence of 
Intravenous (IV) contrast on planning computered tomography (CT) scans of the thorax for 
the radical treatment of lung cancer.  
This study required the relationship between CT numbers and relative electron densities 
(RED) to be also investigated. Research in this area has concluded that CT numbers of high 
atomic number materials, such as contrast, currently can not be accurately converted to RED 
for use in planning. This study therefore used the current CT-RED conversion file to 
investigate the impact of contrast on calculations in the thorax.  
Previous authors who have conducted research on the impact of IV contrast on planning 
calculations have used many different experimental methods. The validity of many of these 
previous studies comes into question due to the experimental designs selected. For this 
reason, this study has been designed to use a research method which is meant to represent 
the actual clinical situation more accurately.  
The optimal experimental design for investigating the dosimetric effect of IV contrast in a 
clinical situation is the pre-test/post-test design. As current protocol at the research location 
is to take pre- and post-IV contrast scans, both were available for data analysis. Assessment 
involved comparing dose calculations on contrast-containing CT scans to non-contrast scans. 
For each patient entered into this study, a plan was completed using both the non-contrast 
and contrast CT scans, keeping the monitor units (MUs) delivered constant. Dose Volume 
Histogram (DVH) data from each plan was collected for analysis. Variables recorded 
included: lung V5, 20 and 30, mean lung dose (MLD), spinal cord maximum dose, 
heterogeneity index, conformity index.  
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Previous researchers have found that the impact of IV contrast on dose calculations in the 
head and neck region was insignificant. However, significant differences have been found 
using phantoms and in some small studies performed on other anatomical sites. Many of 
these studies did not accurately reproduce real clinical situations as they employed 
experimental methods that forced relative electron densities to represent contrast 
enhancement on non-contrast CT scans. This limits the extent to which results from these 
studies can be applied to clinical situations.  
This study found no significant differences between the plans produced on the contrast 
scans and non-contrast scans.   
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CHAPTER 1. INTRODUCTION 
1.1 AIM: 
The purpose of this study is to investigate whether there is a need to account for the 
presence of IV contrast on planning CT scans of the thorax for radical radiation therapy for 
lung cancer. The current protocol for the treatment of lung cancer at my place of work and 
many other departments in New Zealand is to take two scans, one prior to the 
administration of IV contrast and then one immediately following the administration. These 
images are then fused and used to aid in the delineation of the planning targets. The data 
sets are then separated and planning takes place on the non-contrast CT scan data.  
Primary Aim: 
o Investigate the differences produced in the dosimetry when planning in the 
presence of IV contrast compared to scans with no IV contrast present 
Sub Aims: 
o Investigate the accuracy of the CT number – RED conversion for IV contrast.  
o Quantify any errors caused by the CT-RED conversion 
o Make recommendations to the research centre, and other radiation therapy 
departments considering the use of IV contrast in radiation therapy planning of 
the thorax, on the optimal method for planning in the presence of IV contrast.  
This study begins by exploring and reviewing previous research in this area. A full literature 
review is done on previous studies and the optimal process for conducting this type of 
research is discussed.  Some background information on CT numbers and Relative Electron 
Densities (RED) is given.   Two main experiments were then conducted, an investigation in to 
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the CT- RED number conversion which is then followed by the main experiment; the 
investigation in to the effect of contrast on the CT-RED conversion and the degree at which 
this impacts on dose calculations.  These experiments are then flowed by the results and a 
discussion of these. Finally some conclusions and recommendations are made.  
1.2 BACKGROUND 
In New Zealand, lung cancer is the most common cause of cancer death for males and the 
third most common for females ("Cancer: New registrations and deaths 2005", 2008). Whilst 
surgery is a potentially curative treatment for early stage lung cancers, only 20% of cases at 
diagnosis are suitable for surgery as often lung cancer patients have multiple co-mortalities 
and radical surgery is not an option (Cowdy, 2008).  Approximately 70% of patients 
presenting with lung cancer already have locally advanced or metastatic disease, so 
chemotherapy, radiation therapy or a combination of the two are often treatment choices 
(Molina, etal., 2008).  
Statistics show that cure rates in lung cancer are poor ("Cancer: New registrations and 
deaths 2005", 2008), despite extensive research into the best methods to treat these 
cancers. Radiation Therapy  (RT) is often a treatment of choice due to its lower toxicity and 
less invasive approach compared to chemotherapy or surgery. One large Radiation Therapy 
Oncology Group (RTOG) study investigating the use of radiation therapy alone as a 
treatment option only achieved a 10-month median survival and a 5% 5-year survival rate 
(Molina, et al., 2008). Research into stereotactic and hyperfractionated treatments is looking 
more promising but these still require further work before they become a standard practice 
(Haasbeek et al., 2008) (Sher, et al., 2008).  
At my place of employment, MidCentral Health Ltd,  the current standard of care for radical 
radiation therapy for lung cancer is a course of radiation using 60-66Gy in 30-33 fractions 
("Protocol for radiation treatment of Non-small Cell lung cancer", 2003). IV contrast for CT 
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simulation maybe used at the Oncologists’ request to aid in the contouring of the planning 
target volume (PTV). The protocol currently requires the plan calculations be done on a 
normal CT scan without the presence of IV contrast to reduce any perceived errors occurring 
due to the presence of the contrast on the scan.  
In order to understand these recommendations and concerns a good understanding of the 
process in which the treatment planning system (TPS) uses the CT numbers to relate relative 
electron densities (RED) and the factors that influence these is required. The next chapter is 
an introduction to this area of physics along with the aims of the radiation therapy process.  
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CHAPTER 2. BACKGROUND 
2.1 RADIATION THERAPY FOR LUNG CANCER 
The delivery of radiation therapy to the lung has evolved greatly over the years and its 
complexity has increased dramatically. Standard treatments delivered in the 1980-90’s 
consisted of parallel opposed pairs (POP) of treatment beams, which whilst delivering the 
required dose to the tumor, often gave high doses to surrounding structures (Cowdy, 
2008). As research progressed and new techniques were developed treatments progressed 
to three dimensional conformal therapies (3DCRT). This modern method allowed higher 
doses to be delivered to the planning target volume (PTV) and helped minimize dose to the 
organs at risk (OAR).   With this ability to more accurately deliver radiation therapy the need 
to more accurately define the PTV and OAR increased. 
The aim of radiation therapy planning is to deliver the prescribed dose to the target volume 
whilst minimising dose to surrounding sensitive structures. In order to achieve this 
accurately, PTVs and OARs need to be clearly identifiable on CT images.   The use of 
contrast-enhanced CT scans in radiation therapy planning has enabled more accurate 
delineation of planning target volumes and sensitive structures (Lees, et al., 2005).   
Radiation therapy treatment planning systems (TPS) use the data from planning computed 
tomography (CT) scans to provide information on the patient’s size, the location of 
structures and information on the density of any inhomogeneities present.  TPS use the 
information about these inhomogeneities to calculate the way radiation may interact with 
the tissue, and the resultant dose to the patient/structures can then be accurately 
calculated.   
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The aim of simulation, prior to treatment planning, is to place the patient in the treatment 
position and obtain images that ‘simulate’ the patient’s external and internal anatomical 
position during treatment to enable accurate treatment planning (Washington & Leaver, 
1996). Intravenous contrast, used in planning CT scans, is present during the CT planning 
scan but not during the actual treatment of the patient. The presence of this contrast on the 
planning CT scan may alter the electron density of the tissues. The contrast presence during 
the scan for planning and absence during treatment would be expected to lead to significant 
inaccuracies in planning calculations and this effect needs to be quantified.   
One current practice is to take pre- and post-intravenous (IV) contrast CT scans. This method 
has been designed to incorporate the benefits of IV contrast for visualisation of anatomy 
whilst reducing the perceived errors in dose calculations that may be caused by the 
presence of the IV contrast. The two scans are ‘fused’ and the contouring of OAR and PTV is 
done using the IV contrast scan. The scans are then separated and the planning is done on 
the non-contrast scan only.   
The assumption is that the contrast will affect the RED to a degree in which the planning 
calculations are inaccurate. This is the basis of this investigation and a good understanding 
of how this may occur is needed and information on what degree RED are affected by IV 
contrast is required. The following section reviews the physics behind these calculations.  
 
2.2 CT DATA AND RADIATION THERAPY TREATMENT PLANNING 
Computed tomography involves the measurement of the radiation attenuation of an object. 
Information is gathered by passing radiation through an object and measuring the intensity 
of that beam after it has been attenuated by the object in its path. This information is then 
converted to an electrical signal that is reconstructed into an image using convolution and 
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back projection algorithms (Seeram, 2001).  CT images are made up of pixels; each pixel is 
assigned a CT number which is related to the linear attenuation coefficient of that tissue (µ) 
(Seeram, 2001). CT numbers are determined using the following equation: 
Equation 1. CT number 
 
                            µt -µw 
CT number = ------------- . K, 
                            µw 
 
 
where µt  is the attenuation coefficient of the tissue and µw  is the attenuation coefficient of 
water and K is a constant = 1000 (Seeram, 2001).  
Because CT numbers are derived using a kilovoltage photon beam and radiation therapy is 
delivered using a megavoltage photon beam, a relationship between CT numbers and the 
attenuation properties of tissues when they interact with photos of megavoltage energies  is 
necessary (Plessis, et al., 1998). Kilovoltage beams are significantly affected by photoelectric 
attenuation, which is highly influenced by atomic number (Z). Therefore the data produced 
during the CT process is largely a result of interactions influenced by the atomic number for 
the materials present. Soft tissue has a Z ~ 7.5, and contrast media has a Z ~ 53 due to its 
iodine content (IAEA, 2005). 
 
Megavoltage energies in the range of 4-18 MeV are most commonly used for radiation 
therapy treatment. These treatment energies have mean photon energies of 2-6 MeV that 
are mostly affected by Compton scatter as they pass through human tissue, with a small 
percentage of pair production at the higher energies (IAEA, 2005). With these energies, the 
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degree of attenuation is more dependent on electron density (Washington & Leaver, 1996) 
(see Graph 1). This difference in photon interactions probably will result in different 
attenuation coefficients. Therefore a relationship is needed between the CT numbers and 
electron densities. This is achieved by the use of electron density conversion files that are 
often described in relation to water (relative electron densities – RED) (Plessis, et al., 1998).   
Graph 1. The effect of atomic number and photon energy on radiation interactions 
 
 (IAEA pg: 37, 2005) 
CT –RED conversion has been proved accurate for the conversion of matter such as soft 
tissue which has a relatively small atomic number range.  The issue and main area of debate 
is the ability to convert higher atomic number materials such as contrast or metal to RED 
accurately (Coolens & Childs, 2003).  As CT numbers are obtained as a function of the mass 
density and atomic number,  and RED is a function of mainly the mass density, a high CT 
number (such as for contrast or metal) may be a result of either high atomic number or mass 
density, therefore the accuracy of such number is debated.   This is investigated in 
experiment one.  
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Lung cancer is a serious problem causing many deaths per year in New Zealand. Radiation 
therapy is an important treatment method for this condition. The use of CT scanning to 
accurately define the treatment volume is the standard method of simulation for radiation 
therapy planning. It is established that contrast can aid in the accurate delineation of the 
PTV and OAR, and that contrast may in fact impact on the accuracy of the dose calculations. 
Other researchers have investigated this problem. The following is a review of the previous 
research in this area.  
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CHAPTER 3. LITERATURE REVIEW 
 
The literature review begins with a review of the experimental research done into the 
influence of the contrast on dose calculations, using mostly phantoms. This is then followed 
by review of research done on specific body sites including head and neck, abdomen and 
thorax. The optimal methods for performing this type of research is reviewed as well as 
indices that may indicate the impact on the resultant plans.  Finally, research in to the 
accurate conversion of CT-RED number is investigated.  
 
3.1 EXPERIMENTAL RESEARCH IN TO THE INFLUENCE OF CONTRAST ON 
DOSE CALCULATIONS:  
In 2001, Ramm, Damrau, Mose, Manegold ,Rahl and Bottcher performed an investigation 
into the influence of contrast agents on dose calculations. The researchers used a phantom 
filled with water containing cylinders of various dimensions containing differing 
concentrations of contrast media. The researchers scanned this phantom and applied basic 
planning techniques. The researchers investigated a number of variables: the concentration 
of the contrast used, the diameter of cylinder containing the contrast and the treatment 
planning technique, 2 field vs 4 field beam arrangement (Ramm et al., 2001).   
This study found that the use of contrast media led to a change in the MUs calculated.  They 
found that the difference increased linearly with the molarity of the contrast and the 
diameter of the cylinders containing contrast.  The researchers also found that with 
increasing beam numbers, dose inaccuracies decreased.  They found significant differences 
in the MUs produced when the contrast was in vessels larger  than 5cm in diameter and in a 
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concentration that increased the CT numbers by more than 500 Housfeild units (HU) (Ramm 
et al., 2001).   
These conclusions, whilst beneficial in providing information on the impact of different 
possible variables, are not relevant to actual clinical situations. The researchers performed 
many tests and analysed large amounts of data, but the data is not strictly representative of 
the physiological uptake of contrast media in human tissues, and used planning techniques 
that are no longer commonly used for radical cases. A further study has shown that, under 
normal conditions, IV contrast will not increase the CT number of tissue by more than 500 
and, apart from the heart itself, blood vessels in the human body do not normally exceed 
5cm in diameter (Lees, et al., 2005).  
The effect of the presence of IV contrast in lung tissue was investigated by Lees, Holloway, 
Fuller and Forstner (2005).  These researchers felt that an investigation using actual patients 
would be unethical, so elected to use an anthropomorphic phantom. This thorax phantom 
was made up of similar electron density materials to the actual tissues found in the human 
thorax.   
The researchers performed two investigations. Firstly, they inserted straws of various 
concentrations of contrast into the ‘lungs’ of the phantom in an area said to represent the 
tumour mass. This was then scanned and a simple plan consisting of three beams was 
applied to the data obtained from the scan.  This was then repeated without the presence of 
contrast in the straws.  The resultant MUs from both plans were compared and differences 
(<1.5%) were deemed insignificant (Lees, et al., 2005).  
This first investigation may not be clinically relevant. The researchers suggest that this is 
simulating the uptake of the contrast media in the tumour mass; however tumour 
vascularity varies dependent on tumour type and the presence or absence of necrosis. This 
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study also completely ignores the possibility of IV contrast present in the large blood vessels 
in the mediastinum and the uptake in the small blood vessels of the lungs, which may impact 
significantly on MU calculations.  
  
3.2 RESEARCH ON THE EFFECT OF IV CONTRAST ON HEAD AND NECK 
RADIATION THERAPY PLANNING: 
Two recent studies on the use of intravenous (IV) contrast-enhanced CT scans for  intensity 
modulated radiation therapy (IMRT) planning of the head and neck region  have concluded 
that the presence of contrast on the CT images does not result in clinically significant errors 
in dose calculations (Choi et al., 2006; Liauw,et al., 2005).  Both sets of researchers agree 
that the use of IV contrast is essential for the accurate and extensive contouring required for 
IMRT planning.   Both studies used similar experimental methods.  
Liauw and colleagues (2005) did a small study on five patients having IMRT for head and 
neck carcinomas. This research was done using only contrast-enhanced CT scans. The organs 
at risk (OAR) and planning target volumes (PTVs) were contoured, along with the contrast-
containing vessels visible in the neck region. The IMRT plans were completed on the contrast 
scan then repeated on the same scan, with the density of the contrast-containing vessels 
altered.  The differences in the plans produced were then analysed (Liauw, et al., 2005). A 
major flaw in this experiment design is the ‘forcing’ or altering of the density of the 
contoured vessels only. Altering the density in the vessels alone does not completely 
eliminate the effect of the presence of contrast in other tissues, which may have an effect 
on dose calculations. For an accurate evaluation of the effects of the intravenous contrast on 
dose calculations, scans before and after contrast administration should be compared.  
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Choi and colleagues (2006) performed a slightly larger study investigating the effects of IV 
contrast on fifteen patients receiving IMRT to the head and neck. These patients were 
scanned without the contrast, then immediately rescanned in the same position after the 
administration of IV contrast. The IMRT plan was completed on the contrast scan, then the 
exact same parameters were applied to the non-contrast scan and the plan re-calculated. A 
comparison and analysis was then made (Choi et al., 2006).   One would assume that the 
comparison between the two scans would be more akin to the real occurrence when the 
patient attended for treatment without the presence of any IV contrast.  
Both studies concluded that the presence of IV contrast made no clinically significant impact 
on the dose calculation to the OAR or the PTVs. They found minor changes in the MUs 
calculated but concluded that these small differences were insignificant (Choi et al., 2006; 
Liauw, et al., 2005).  
Ramm et al. (2001) concluded that, with an increase in the beam numbers, the effect of IV 
contrast on dose calculations decreases. IMRT uses a large number of beams, so perhaps 
this is the reason for this apparent insignificant impact on MU calculation. Ramm et al., 
(2001) also concluded that the diameter of the vessels containing the contrast impacted on 
the MU calculations.  Head and neck sites have relatively small blood vessels, and these may 
have less effect than the larger vessels found in the thorax and abdomen, which were not 
investigated in the Choi et al., (2006) or Liauw et al., (2005) studies. 
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3.3 RESEARCH ON THE EFFECT OF IV CONTRAST IN OTHER RADIATION 
THERAPY PLANNING SITES: 
Lees, Holloway, Fuller and Forstner (2005) conducted a 2-phase study on the effect of IV 
contrast on dose calculations in lung tissue; their first investigation involved a phantom as 
described earlier in this review. Lees et al.’s (2005) second investigation involved the 
manipulation of the electron densities on the scan of an actual patient, forcing the electron 
density of the lungs to a mean electron density calculated from six patients’ contrast-
enhanced lung scans (Lees, et al., 2005).  
This was designed to simulate the actual density changes due to the absorption of contrast 
agents in the smaller vessels of the lung tissue. This study found that the RED of non-
contrast lungs was on average 0.23, whereas with the contrast-enhanced lungs, the RED was 
increased to 0.38.  The same plan was applied to the normal and the forced density scans; 
the results were then analysed.  The MUs calculated and the mean lung doses were 
compared and the conclusion stated that the differences were minor and insignificant (Lees, 
et al., 2005).   
This study failed to investigate the impact of the large vessels of the heart and lungs being 
filled with the contrast. The Ramm et al., (2001) study concluded that the size of the vessels 
containing the contrast related to the degree of errors in dose calculations. This study also 
forced the RED of the lungs to the average RED for six normal lung scans. One could assume 
that lung cancer patients have lungs that may vary in RED after the uptake of IV contrast, 
due to changes in the vascularity of the lungs as a result of their pathology.  
An earlier Australian study (Miller & Joon, 2002) researched this topic using an experimental 
design that more accurately mimicked the actual situation when IV contrast is no longer 
present for treatment. Scans were taken pre- and post-contrast, and the same plans were 
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compared on both scans. This study was however limited by a small sample size of just 10 
patients (Miller & Joon, 2002).   
This study introduced another variable –  the breath hold. The reason for introducing this 
second variable is unclear, as radiation therapy treatment is usually given in a ‘free 
breathing’ situation, and scanning in a ‘breath hold’ situation is not representative of actual 
treatment, unless gated treatment is an option. Currently in New Zealand and Australia, 
gated treatment is not often used.  The design of this research is such that you cannot 
separate the effects of breath hold and IV contrast, and this makes the comparison difficult. 
There were many flaws in Miller and Joon’s (2002) experimental design. The evaluation was 
done by keeping the doses the same, and evaluating the differences in MUs needed to 
deliver this dose in contrast/breath hold scans, versus non-contrast/free breathing scans 
(Miller & Joon, 2002).  Whilst this did show that there can be significant changes in the 
number of MUs required to deliver the same dose, the clinical significance of this is not able 
to be clearly distinguished.  It would have been more clinically significant to keep MUs 
constant and evaluate the resultant changes in dose delivered. Another flaw of this article is 
the lack of information on the type and concentration of contrast media used. Previous 
studies have shown that these variables can affect dose distributions (Ramm et al., 2001).  
Another Australian study (Rudolph et al., 2007) was an investigation into the effects of IV 
contrast on planning stomach cancer patients. This study reviewed ten cases of stomach 
cancer; the patients had a non-contrast scan immediately followed by a contrast-enhanced 
scan.  This study used a variety of methods, including dose volume histogram (DVH) analysis, 
plan subtraction and estimations of biological endpoints, to evaluate the differences 
between the non-contrast plans and the contrast plans. The conclusion of this study found 
that the difference between the two plans was insignificant and that the non-contrast scan 
was not required (Rudolph et al., 2007). This study used a similar method to Miller and Joon 
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(2002), and kept the dose delivered constant and varied the MUs required to deliver this 
dose. In order to confirm the insignificance of the impact of IV contrast, an absolute dose 
comparison is needed to compare the actual clinical significance of the presence of IV 
contrast at the time of planning.  
A recent study reviewed was that of Shibamoto, et al., (2007). These researchers 
investigated the impact of contrast materials over a number of sites including whole brain, 
head and neck, mediastinum, whole pelvis and abdomen. Unfortunately, this study is limited 
by its use of very small study sets for each site of only 5 patients, each of whom had a range 
of different cancers at different stages and grades.  
These patients received both pre and post IV contrast CT scans and planning was performed 
on the contrast data set, then copied to the non-contrast set. The planning techniques used 
were simple parallel opposed pairs.  This study, like others reviewed, kept the dose constant 
and analysed the MU differences required pre and post-contrast to deliver the prescribed 
dose. The researchers found in most cases the differences were insignificant except in upper 
abdominal patients who required an increase in MU by an average of 3.2% and, in one case, 
by 7.6% to deliver the same dose post-contrast compared to the pre-contrast data. The 
researchers stated a number of possibilities for this difference, including the presence of the 
liver and spleen which up took a lot of the IV contrast, coupled with differing anatomical 
positions between the two CT scans due to the effect of the patient breathing throughout 
the scanning process (Shibamoto et al., 2007).   
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3.4 INVESTIGATING THE IMPACT OF IV CONTRAST: 
One of the main weaknesses of previous studies on the impact of IV contrast on dosimetric 
calculations for planning radiation therapy has been the methods used to compare the two 
plans. The majority of the studies reviewed decided to investigate the differences in the 
MUs required to deliver the prescribed dose with or without the presence of IV contrast on 
the planning CT (Choi et al., 2006; Liauw, et al., 2005; Miller & Joon, 2002; Rudolph et al., 
2007; Shibamoto et al., 2007).  
The aim of this study is to investigate the possibility of planning on a CT scan containing IV 
contrast, then applying that plan in the clinical setting without concern that the dose 
delivered has been miscalculated due to the presence of the IV contrast on the planning 
scan.  Therefore, the most relevant way to investigate this possible miscalculation would be 
to keep the MUs consistent between the plans, and investigate the differences in the dose 
delivered.   This method would then enable the results to demonstrate the differences that 
occur as a result of planning on a CT scan with IV contrast, then delivering the MUs 
calculated on that plan to a patient without the presence of IV contrast. This method should 
demonstrate the clinical impact of a department’s decision to plan in this manner.  
 
    3.5 COMPARING PLANS: 
When comparing two plans, there are many variables that can be used to assess the 
differences and quantify the plans’ conformity with the aims of treatment. Since the 
development of 3DCRT planning, many quantitative indices have been postulated as optimal 
tools for evaluating radical lung plans (Armstrong, 2007; McGibney, et al., 2003). For this 
study, the most commonly reported indices have been chosen to provide information on the 
variations between the two plans; one with IV contrast present and one without.  
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 Lung dose including reporting on V5, V20, V30 and mean lung dose (MLD) 
 Spinal Cord - maximum point dose 
 Heterogeneity index (HI) 
 Conformity index  (CI) 
 
3.5.1 LUNG DOSE 
 
Radiation-induced pneumonitis is a major limiting factor in the delivery of optimal radiation 
therapy to the lung.  Many studies have shown that total lung V20 and mean lung dose 
(MLD) are good variables for demonstrating the risk of radiation pneumonitis (Chang et al., 
2006; Kocak et al., 2007; Seppenwoolde et al., 2003).   
A lung V20 is the volume of the total lungs that receives 20Gy or more. Whilst studies show 
a range of recommendations for limiting the V20, from 28-17%, my place of employment  
has decided to use a planning recommendation to limit lung V20 to 20% ("Protocol for 
radiation treatment of Non-small Cell lung cancer", 2003).  V30 and V5 have also been 
chosen as variables in this study to investigate any smaller differences in lung dose variation 
as a possible result of planning on a plan with IV contrast present.  
Mean Lung dose (MLD) is the most recommended measure for predicting radiation 
pneumonitis.  The risk of radiation pneumonitis increases linearly with increasing MLD ( 
Chang et al., 2006). Chang et al., (2006) recommends that MLD be kept below 17Gy.  
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3.5.2 SPINAL CORD DOSE 
The spinal cord variable used in this study is the maximum point dose. This has been 
selected as the spinal cord is an important serial sensitive structure to consider when 
planning radical radiation therapy in the thorax (ICRU, 1999). The function of a serial 
sensitive structure is damaged when any part of that structure surpasses the tolerance dose 
for that tissue.  The tolerance of the spinal cord is reported by Emami et al., (1991) with a 
TD5/5 of 50Gy to  5-10cm length or 47Gy to a 20cm length. However, as the spinal cord is a 
serial structure, a maximum point dose is preferred as an optimal reporting tool (Emami et 
al., 1991). My place of employment has decided to recommend that, when planning 
radiation therapy to the thorax, the maximum point dose to a spinal cord should aimed to 
be kept below 45Gy ("Protocol for radiation treatment of Non-small Cell lung cancer", 2003)  
 
3.5.3 CONFORMITY AND HETEROGENEITY INDEX 
The final two variables selected for this study are the conformity index (CI) and the 
heterogeneity index (HI).  The conformity index is the volume of tissue enclosed by the 95% 
isodose curve, or the ‘treated volume’, divided by the volume of the PTV (Armstrong, 2007). 
The method of finding the CI has been described by the TROG 03.04 ‘RADAR’ trial (TROG, 
2004). To calculate a CI, a new structure called the CI box is created with a margin on the 
PTV to encompass the 95% isodose curve. CI is calculated using the following equation: 
Equation 2. conformity index 
A. = total volume of PTV 
B. = Volume of the 95% within the CI box 
CI = B/A 
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 The conformity index is a measure often used to assess if a plan is ‘optimal’. The ideal CI 
would equal 1; however, this is not a realistic aim for thorax plans. The larger the CI, the less 
conformal the plan is and the more normal tissue is unnecessarily irradiated to the dose 
required to achieve the aim of treatment. Armstrong (2007), strongly recommends the use 
of a CI when comparing plans in which technology or technique need accurate comparison. 
Chang, Zhang & Cox (2007) argue that whilst CI is an important variable to assess, it must be 
balanced in thorax plans with other variables such as the lung V5 and MLD (J. Y. Chang, etal., 
2007). 
The heterogeneity index (HI) is a ratio between the maximum dose and the prescribed dose; 
this should be kept as close to one as possible. ICRU 50/62 recommends that the dose across 
the PTV should be kept between -5% and +7% of the prescribed dose.  
 
3.6 CT-NUMBER TO RED CONVERSION 
 Studies show that CT numbers can vary significantly; for example  Coustantinou and 
Harrington (as cited in Schneider, et al., (1996)) found that the CT number of a homogenous 
material can vary between 1-2%. They also found that accuracy is dependent on the location 
of a material within the image, and errors can reach 3% in the periphery of a CT image. 
Coustantinou and Harrington also found that CT numbers can vary greatly between scanners 
and a variation of up to 10% can be found between different CT scanners.  However, 
because these differences are referring to CT numbers, and TPS convert these to RED, which 
has a much smaller range of numbers (0~1.7) than CT numbers (-1000 ~1000), a variation of 
up to 10% in CT numbers would equate to very minor, perhaps insignificant, changes in RED.  
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Plessis, et al., (1998) found that CT number intervals of 30 for soft tissues and 100 for bone 
would result in insignificant changes in dose calculations in TPS (Plessis, et al, 1998). Chu. et 
al., (2000) did a similar investigation and found that a change of CT number of 20 in soft 
tissue and 250 in bone resulted in less than a 1% change in MU calculations (Chu, et al., 
2000).  Thomas (1999) did further investigations into the range of RED values required to 
make a 1% or less change in the dose and produced the following table: 
Table 1. Percentage change in tissue maximum ratio (TMR) per cm of depth and the change in depth 
required to produce a 1% change in TMR used to calculate the range of RED that would give a dose 
correction factor within 1% of those calculated for typical in homogeneities 
 
(Thomas, 1999, pg 783) 
Whilst investigating contrast calculations using the XiO planning system, it was discovered 
that the system would ‘cap’ the CT-number to RED conversion at a CT value of 1152 
equating to an RED of 1.71. Upon further investigation, it was noted that the planning 
system was labeling areas of IV contrast as having an RED of 1.71 (the highest limit) – 
therefore, the actual RED could be much higher and the planning system was not accurately 
accounting for the IV contrast.   The CT number -RED experiments in this thesis were 
formulated to attempt to account for this inaccuracy in the planning system. 
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3.7 RESEARCH IN CT-RED CONVERSION 
A number of researchers have investigated methods for finding accurate RED of higher 
atomic number materials. Coolens & Childs (2003) investigated two methods for obtaining a 
CT-RED conversion file for metallic materials. Firstly, they calculated theoretical electron 
densities of the materials to be tested using atomic composition, then calculated the 
electron density using CT numbers and compared the results. These two methods did not 
result in RED of the same value for each material and highlight that there is a need for a 
better way to determine RED of higher atomic number materials. Coolens & Childs (2003) 
second experiment involved stoichiometric calibration; this also failed to achieve a match 
between the theoretical electron densities and those obtained using stoichiometric 
calibration using CT numbers.   
Ramm (2001) investigated how high atomic number contrasts such as barium affect dose 
calculations in 3D treatment planning.  Ramm found that using CT to measure the 
Hounsfield numbers of various concentrations of barium sulphate did not produce a linear 
graph, and accounted this to the beam-hardening effect of CT scanning materials of high 
atomic number. The problem of beam-hardening in CT using kilovoltage may be avoided 
using MVCT; this is a possibility currently being investigated by other researchers. 
Plessis et al. (1998) investigated the use of CT numbers to establish material properties 
needed for Monte Carlo calculation of dose distributions and found that in order to make 
dose calculations accurate to 1%, CT number intervals of 30 in soft tissue and 100 in bone 
can be used.  As the RED of the tissue increased (i.e. from soft tissue to cortical bone), the 
influence of the change in CT number on dose calculation accuracy decreased. Extrapolating 
this on to much higher RED materials such as IV contrast and metal, one may assume even 
larger intervals in CT numbers could be used and still maintain dose calculation accuracy of 
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1%.  Unfortunately, Plessis and his fellow researchers did not investigate this with higher 
density materials.  
A theme occurring from these studies is that the relationship between high RED materials 
and CT numbers cannot be assumed to be linear. Unfortunately, one solution commonly 
used in radiation therapy departments to account for high RED materials is to simply extend 
the CT-RED conversion file linearly, based only on tests of lower atomic number tissues. 
Whilst this is relevant for most situations in radiation therapy planning where patients are 
mostly made up of low atomic numbers, when high atomic number materials such as iodine 
or barium based contrasts or metallic implants such as hip replacements are present, our 
dose calculations may be becoming less accurate.  Thomas (1999) warns of the inaccuracies 
that occur when you try and apply currently used equations to relate CT-numbers and RED in 
higher atomic number materials such as metal implants (Thomas, 1999).  
The need to accurately represent the RED of higher atomic number materials is important as 
most departments now use CT data and 3D planning techniques (Saw et al., 2005). The 
increasing addition of IV contrast use in obtaining planning images also necessitates accurate 
CT- RED conversion files.   
An experiment was needed to determine the effective RED of much higher atomic number 
materials, as previous studies have proven that directly relating CT numbers to known or 
theoretical REDs of tissues of higher atomic number materials can lead to inaccuracies 
(Thomas, 1999). This experiment, conducted to help support the results of the main thesis, is 
described in chapter 4. 
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3.8 LITERATURE REVIEW AND SUMMARY 
The review of this literature has shown that solid conclusions on the impact of IV contrast on 
planning calculations are still not achieved. Researchers are confident that the impact on 
areas such as the head and neck are minimal, but there is still some doubt and debate in the 
areas with larger blood vessels such as the thorax. This has lead to this investigation on the 
impact of contrast when planning radical lung cancer treatment.  
Research in to the conversion of CT number to RED has also shown this is an area where 
inaccuracies exist and can be difficult to quantify. This has lead to experiment one – the CT-
Number conversion investigation in Chapter 4.   The literature review has highlighted the 
optimal method for the main experiment and indicated the appropriate indices for 
assessment of the plans. The main experiment is conducted in Chapter 5. 
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CHAPTER 4. CT NUMBER-RED CONVERSION 
INVESTIGATION 
4.1 AIM: 
 Investigate the relationship between CT numbers and RED for IV contrast and higher 
atomic number materials 
4.2 METHOD 
 4.2.1 PART ONE:  
Standard calibration conditions for 6MV photons were set up on a treatment unit using a 
10x10 cm field, 100cm source to axis distance (SAD), with a dose point measured at 5cm 
depth in plastic water. Different materials were placed in the beam path and the dose at the 
5cm depth was recorded when 100 MU were delivered. 
Figure 1. Experiment one set up 
 
 
Dose 
delivered at 
5cm depth 
after 100 
MU 
delivered 
was 
measured  
Different materials 
placed in beam 
path 
100cm 
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Table 2. Measured dose delivered per 100 MU post absorption by various materials 
 
 
 
 
Date:  13/10/2008 Measured by: 
Aitang and 
Hannah Gantry: zero 
Machine:  LA1 6MV Field size: 10cm by 10cm Collimator: zero 
Depth: 5cm Temperature: 21.7   
Phantom: 
Plastic 
water Pressure: 
771mmHg 
  
Materials: Readings(nC) Average(nC) 
Dose at 5cm 
depth(cGy) 
Output at 
dmax(cGy) 
Plastic 
water 20.19 20.19 20.19 95.3 
100.1 
Steel 4.34 4.334 4.337 20.5 
Lead 7.758 7.751 7.7545 36.6 
Brass 10.17 10.17 10.17 48.0 
Contrast 17.04 17.04 17.04 80.4 
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4.2.2 PART TWO: 
Using the same set up as the treatment measurements, the phantom with the various 
materials was then CT scanned.  The scan was taken using the ‘extended CT number scale’ 
option available on the Siemens scanner.  
Table 3. Hounsfield numbers and Xio’s derived RED of measured materials  
Material Average Hounsfield number Standard deviation Derived RED 
Steel 5692.63 95.6 >10.24 (XiO limit) 
Lead 5188.186 219.5 6.7 
Brass 5123.22 146.8 6.35 
IV contrast 3921.7 28.3 1.35 
The standard calibration conditions were then modeled in the planning system (CMS XiO, 
Version 4.4) using the scanned data for each of the materials tested. The RED of the material 
was then forced to various REDs until the dose at the 5cm point in the plastic water was 
achieved using the set 100 MUs.  
Graph 2.Derived RED to CT values showing non-linear relationship  
CT number - RED relationship of organic materials 
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4.2.3 RESULTS AND DISCUSSION: 
This small experiment has shown that with the addition of higher atomic number materials, 
the relationship between RED and CT numbers can no longer be called linear, and that there 
is potential error in using a linearly extended RED-CT conversion table to estimate the effect 
of IV contrast in planning calculations. Looking further at the data collected in this 
experiment, there appear to be two different effects occurring between the two groups of 
materials, low atomic number and high atomic number.  
 
Graph 3. Derived RED to CT values showing low and high atomic number differences  
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Further investigation is therefore needed to investigate the RED-CT number relationship of 
IV contrast. 
4.2.4 PART THREE:  
To further investigate the CT – RED curve created by IV contrast, further experiments were 
required using various strengths of IV contrast.  Measurements of the dose at a point were 
taken when 100 MU was delivered through a vessel containing mixtures of 100%, 66%, 50%, 
33% and 20% Omnipaque 350 IV contrast diluted in distilled water as per the following 
diagram.  
Figure 2. Experiment two set up 
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Dose 
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10cm depth 
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 Initially, the data was used to discover the potential errors in the dose calculations 
performed by XiO using the current CT-RED conversion table; the measured doses at the 
isocentre were compared with the calculated doses at the isocentre.  
Table 4. Dose measurements delivered per 100 MUs after being absorbed by various 
concentrations of omnipaque 350 contrast, using 6MV  
 concentrations of contrast 
measurements in nC at 
6MV 100.0 66.0 50.0 33.0 20.0 0.0 
1 11.460 11.620 11.650 11.640 11.720 14.000 
2 11.450 11.610 11.650 11.640 11.710 14.020 
3 11.460 11.613 11.640 11.630 11.713 14.000 
average 11.45667 11.61433 11.64667 11.63667 11.71433 14.00667 
dose (cGy) per 100MU 55.43693 56.19986 56.35631 56.30793 56.68374 67.77597 
 
Table 5. Dose measurements delivered per 100 MUs after being absorbed by various 
concentrations of omnipaque 350 contrast, using 15MV  
 
 
 
       
 concentrations of contrast 
Measurements in nC at 
15MV 100.0 66.0 50.0 33.0 20.0 0.0 
1 13.890 14.040 14.070 14.080 14.130 17.220 
2 13.880 14.040 14.070 14.080 14.130 17.250 
3 13.880 14.030 14.080 14.100 14.150 17.240 
average 13.88333 14.03667 14.07333 14.08667 14.13667 17.23667 
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Table six shows that the potential error in these examples between XiO’s calculated dose 
and the measured dose is approximately 11% for 6 MV and 12% for 15 MV.  
Table 6. Comparing XiO’s calculated doses with measured doses after being absorbed by 
various concentrations of Omnipaque 350, using 6MV 
     
IV 
contrast% 
Averaged measured 
dose with 100MU 
Averaged XiO’s calculated dose 
(unforced REDs) differences 
% 
difference 
100 55.4 61.5 6.1 11 
66 56.2 63.2 7 12 
50 56.4 63.6 7.2 13 
33 56.3 64.3 8 14 
20 56.7 65.3 8.6 15 
0 67.8 68.6 0.8 1 
ave 56.2 63.58 7.38 11 
SD 0.48 1.41 0.96   
 
Table 7. Comparing XiO’s calculated doses with measured doses after being absorbed by 
various concentrations of Omnipaque 350, using 15MV  
15MV     
IV 
contrast% 
Averaged measured 
dose with 100MU 
Averaged XiO’s calculated dose 
(unforced REDs) differences 
% 
difference 
100 66.2 76.1 9.9 15 
66 66.9 77.6 10.7 16 
50 67.1 77.9 10.8 16 
33 67.2 78.4 11.2 17 
20 67.4 79.3 11.9 18 
0 88.2 82 -6.2 -7 
ave 66.96 77.86 10.9 12 
SD 0.46 1.18 0.73   
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Graph 4. XiO’s calculated dose compared with measured doses per 100 MU for 6 MV 
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Graph 5. XiO’s calculated dose compared with measured doses per 100 MU for 15 MV 
50
60
70
80
90
100
0 20 40 60 80 100
% IV Contrast
D
o
s
e
15MV Averaged measured dose with 100MU
15MV Averaged Xios calculated dose (unforced REDs)
 
Hannah Thompson Page 43 
A 11-12% inaccuracy is large and this is under controlled experimental conditions; therefore 
a way to correct for this inaccuracy needs to be determined. Although a complete correction 
is not possible, due to many influencing factors such as contrast size and concentration, a 
more accurate CT-RED conversion table could be created to provide data that may model a 
more realistic CT-RED conversion with higher atomic number substances.  
4.2.5 PART FOUR:  
In order to determine a more realistic CT-RED conversion graph, experiment one was 
repeated on the 2nd set of data and the RED of the various concentrations of Omnipaque 350 
was forced until the dose at the point calculated by XiO equaled that of the measured dose 
at the point.  
Table 8. Average Hounsfield numbers and derived RED for various concentrations of 
Omnipaque 350 contrast 
concentration of contrast % 
Average 
HU SD derived RED 
100 2931.4 111.9823 2.8 
66 2240.5 173.2854 3.1 
50 1871.8 49.05281 3.2 
33 1359.7 14.57586 3.3 
20 904.9 7.156194 3.1 
 
One would assume that as percentage contrast concentration increased, the RED would also 
increase. This experiment has shown that this is not the case; it has shown that a change in 
HU of nearly 2000 makes a change in RED of only 0.2-0.3. If we look at the known data of 
low atomic number material, a change in 0.2-0.3 RED is a change of ~650 HU, showing that 
the relationship is not linear. 
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4.3 DISCUSSION AND CONCLUSION: 
These experiments have shown that the assumption that the RED-CT number file can be 
extended linearly to account for higher atomic numbers is incorrect.  An attempt has been 
made to determine a suitable graph for relating the CT number and RED of IV contrast; this 
has proven difficult and beyond the scope of this masters thesis in Health Science. I have 
been able to determine the error produced currently by the use of the standard CT-RED 
conversion file (un-extended) and found this to be in the realms of 10-12%.  However, this 
error is for a single beam at standard calibration conditions. The Ramm et al. (2001) studies, 
which are discussed further in this document, concluded that with an increase in beam 
numbers, the effect of IV contrast on dose calculations decreases. A 10-12% error with one 
beam should decrease with the increasing beam numbers used in 3D conformal Radiation 
therapy planning, as used in this study. 
Plessis, et al., (1998), and Chu. et al., (2000) did studies, discussed previously,  that showed 
large changes in CT numbers in higher atomic number materials resulted in smaller changes 
in RED, and that these changes produce very little difference in MU calculations (1%).   
The potential error here has been investigated and attempts made to quantify it. It is 
certainly an area that requires further investigation.  For the purposes of the main 
experiment, in chapter 5, the decision to use the capped standard CT-RED conversion file 
was made. This is justified as this represents the clinical situation as it stands, and the use of 
current technology.  The impact of planning on a capped conversion file will be 
demonstrated in the experiment and will yield the required results and show the impact of 
using calculations based on this conversion file on the scan without contrast present.  
In the next chapter the main experiment is conducted. 
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CHAPTER 5. AN EXPERIMENT TO MEASURE DOSIMETRIC 
IMPACT OF IV CONTRAST ON LUNG PLANS  
5.1 EXPERIMENTAL METHOD 
Previous authors who have conducted research on the impact of IV contrast on planning 
calculations have used many different experimental methods. The validity of many of these 
previous studies comes into question due to the experimental designs selected. For this 
reason, this study has been designed to use a research method that is meant to represent 
the actual clinical situation more accurately so that accurate conclusions on the effect of the 
IV contrast can be drawn.   
The optimal experimental design for this situation is the pre-test/post-test design. This 
method enables investigations into the impact of the IV contrast on the dose calculations to 
be accurately assessed. The study has been designed to imitate what would happen in the 
clinical setting if only one scan had been taken with IV contrast present. As the additional 
non- IV contrast scan is also obtained, this research design allows the impact of a plan 
optimised on an IV contrast data set to be assessed by placing the plan on to the non-IV 
contrast CT data set. This enables an analysis to be carried out to assess any dosimetric 
differences between the ‘IV contrast CT plan’ and the ‘non–IV contrast CT plan’. This design 
will reproduce the clinical situation of only one CT scan, with IV contrast, may be taken, and 
the patient being treated without the presence of IV contrast in their body.  
Ethics approval for this research was sought and gained from the Central Regional Ethics 
Committee (CEN/07/36/EXP). 
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5.2 SUBJECTS 
All patients from November 2007 till November 2008, who were referred to the department 
for radical radiation therapy to the lung, and deemed suitable to receive IV contrast, were 
reviewed for this study (refer to Appendix 4. Contrast-Enhanced CT Scanning for Radiation 
Therapy Planning – departmental protocol). One patient was excluded when the CT scan 
showed extensive disease, rendering the patient unsuitable for radical treatment. Another 
patient was excluded as the IV contrast was not administered according to the protocol, 
resulting in images with very little IV contrast present.  
Patients with any type, stage or grade of lung cancer and who were prescribed a dose of 48 
Gy or more to be delivered using a 3D conformal technique were included in this study.  
 
5.3 METHODOLOGY 
 
5.3.1 CT SCAN: 
 
All patients were imaged using the RCTS standard IV contrast Radical Chest CT scan process 
(Thompson, 2006) on a Siemens 6-slice ‘Emotion’ helical scanner (Siemens Medical Solutions 
Inc., Forchheim, Germany).  
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The patients were positioned supine in the department’s standard ‘Wingboard’ position, 
which includes thorax immobilisation using a custom-made wingboard, which places both 
arms above the head and supported in a cradle (see figures 3 & 4). Arm positions are 
recorded using a graduated scale along the ‘wings’ of the support. The patients also had a 
knee rest utilised for comfort.  
 
 
 
 
 
 
 
 
 
Figure 4. Patient positioning 
 
Figure 3. Custom wingboard  
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An initial topogram was taken from the level of the oral cavity to 5cm inferior to the 
diaphragm. The first scan was performed as per protocol: a helical CT using 3 mm 
collimation extending from 5cm superior to the apex of the lungs to 5cm inferior to the base 
of the lungs in a free breathing state; this scan is then reconstructed into 4mm slices at 4mm 
increments (Thompson, 2006). An initial isocentre was selected using Siemens dosimetrist 
virtual simulation software (Siemens Medical Solutions Inc., Forchheim, Germany) and this 
position marked on the patient’s skin. Immediately following the initial scan, IV contrast 
consisting of 100 ml of Omnipaque 350 was given, and a second scan using the same 
parameters as the first was performed with a standard 40-second time delay after the 
administration of the contrast (Thompson, 2006).  
5.3.2 CONTOURING: 
The two CT scans, one with and one without the presence of IV contrast, were fused 
together using Coherence dosimetrist software (Siemens Medical Solutions Inc., Forchheim, 
Germany).  A Radiation Therapist (RT) contoured the patients’ skin surface, lungs and spinal 
cord. The lungs are contoured using a 3D algorithmic procedure in the dosimetrist software, 
which has been set to contour the lungs based on a threshold range of Hounsfield units once 
the RT selects the tissue to be identified as lungs. The skin surface contour included the 
couch top and wingboard so that the electron density of these can be accurately accounted 
for; this removes the requirement for any ‘couch factors’ to be added in the planning 
process. This is the department’s normal practice and removes any risk of human error 
when inputting factors, and allows for accurate representation of the actual treatment set 
up in the planning system.   
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Utilizing the fused data sets, the Radiation Oncologist (RO) was able to contour the gross 
tumour volume (GTV) onto the non-IV contrast scan using information from the IV contrast 
scan; this was done using the ‘blending’ tool in the Coherence dosimetrist software to 
change the mixing ratio of the non-contrast and the contrast data set so that the RO was 
able to visualise the contrast data set and then change the mixture to see the non-contrast 
data set. ROs typically contoured onto the non-contrast data set, then checked this GTV 
contour on the contrast data set prior to accepting it as their final contour. When the data 
sets were un-fused, the contours remained only on the non-contrast data set. 
 The clinical target volume (CTV) and planning target volume (PTV) were then created using 
3D auto margins around the GTV. The sizes of these margins were determined individually 
by each radiation oncologist on a ‘patient by patient’ basis, using the radiation oncologists 
personal experience of what would make a suitable margin incorporating the setup and 
internal margins (ICRU, 1999).  The two data sets were then separated and the non-contrast 
data set sent to the treatment planning system - CMS’s XiO (Computerised Medical Systems 
Inc., Missouri, USA). 
The researcher then repeated this contouring on the contrast-enhanced data set using the 
same methods described above. As each scan is taken at different times, there inevitably 
were some differences between the pre- and post-IV contrast scans. When contouring on 
the contrast-enhanced CT, the researcher tried to mimic the contouring on the non-contrast 
CT as closely as possible. As with any manual task on slightly different data sets, there will be 
some unavoidable differences in this contouring, which is a weakness of this method.  
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5.3.3 PLANNING: 
Each patient’s plan was performed by a RT and approved by the RO, according to normal 
protocol. This included the use of a pre-determined relative electron density conversion file 
for the Emotion scanner installed in the department, 3mm grid spacing, superposition 
algorithm and 3D conformal technique on the XiO planning system. This included the use of 
multiple beams and segments or ‘beams within beams’. All plans were done using the non-
contrast data set only. Once the plan was complete, the researcher saved the plan as a 
‘template’. Templates copy the plan’s parameters and allow these to be applied to different 
data sets. The template from the original plan was then placed on the contrast-enhanced 
data set and the plan ‘re optimised’ by the researcher. Weightings and field sizes were 
adjusted to suit, and dose volume histograms (DVH) produced.  The new plan, as optimised 
by the researcher, was then re-saved as a template and placed back on the non-contrast 
data set. The monitor units (MUs) were changed to reflect the MUs calculated for the 
contrast plan. This was to demonstrate the effect of the plan that was optimised on the 
contrast data set on the non-contrast data set, which represents the actual state of the 
patient at treatment. Dose Volume Histograms (DVHs) were produced and data collected for 
analysis.  
5.3.4  DATA COLLECTION: 
DVH graphs were produced using a bin width of 10cGy and a sampling resolution of 0.1cm 
for the specified tissue.  The following data was obtained and recorded from both the non-
contrast plan and the contrast-enhanced plan: 
 Lung V5, V20 and V30 
 Mean lung dose (MLD) 
 Maximum spinal cord dose  
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 Conformity index (CI) 
 Heterogeneity index (HI) 
The method of finding the CI has been described by the TROG 03.04 ‘RADAR’ trial (TROG, 
2004). To calculate the CI, a new structure called the CI box was created with a margin on 
the PTV to encompass the 95% isodose curve. CI was calculated using the following 
equation:   CI = B/A where: 
A= total volume of PTV 
B= Volume encompassed by the 95% isodose within the CI box 
The heterogeneity index (HI) is a ratio between the maximum dose and the prescribed dose, 
which should be kept as close to one as possible. The clinically significant maximum (CSM), 
as defined by ICRU 50/62 (ICRU, 1993, 1999), was used as the maximum dose. This, divided 
by the dose deemed the minimum required to achieve the aim of treatment (95% of the 
prescribed dose), is the HI.   
    HI= CSM/95% RX dose 
The following data was also collected for each patient: 
 tumour type (pathology) 
  location (lobe of lung or mediastinum level) 
 Stage and grade 
 size (in cm³) of the PTV 
 Radiation prescription 
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5.3.5 DATA ANALYSIS: 
As this is a pre/post test experiment, the appropriate statistical analysis would be the testing 
of the paired data using the “paired sample t test”.  When you have two sets of 
measurements, before and after a treatment, the null hypothesis is: 
Ho= there is no difference in the value X before (X1) and after (X2) treatment 
If the p value is more than the threshold (p=0.05), then we can accept the null hypothesis 
that there is no difference between the two scans.  
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5.4 RESULTS 
 5.4.1 LUNG V5 
Table 9.  Lung V5 results, showing % of total lung volume receiving 5 Gy or more with and 
without contrast 
pt 
lung V5 
Non-con 
% 
Con 
% 
HT01 30.9900 29.7700 
HT02 57.3300 60.2900 
HT03 49.1400 51.0800 
HT04 56.6700 57.6700 
HT05 41.1200 40.1300 
HT06 18.5300 18.4900 
HT07 56.2300 58.6000 
HT08 51.9900 50.4600 
HT09 56.7000 57.7700 
HT10 67.0500 73.1600 
HT11 65.9000 61.1000 
HT12 67.0900 64.8900 
HT13 53.2800 54.6200 
HT14 83.3500 86.9300 
HT15 20.7500 20.4800 
MEAN 51.7413 52.3627 
SD 17.69959 18.62055 
 
Graph 6.  Graphical representation of Percentage of total lung volume receiving 5 Gy or more 
with and without contrast 
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P= 0.369577 
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5.4.2 LUNG V20 
Table 10. Lung V20 results, showing the % of lung receiving 20 Gy or more with and without 
contrast 
 
pt 
Lung V20 
Non-con 
% 
Con 
% 
HT01 11.93 11.35 
HT02 29.29 30.7 
HT03 22.22 23.3 
HT04 30.07 30.77 
HT05 20.85 20.65 
HT06 6.64 6.73 
HT07 24.01 24.89 
HT08 23.34 22.54 
HT09 20.84 20.72 
HT10 31.39 35.97 
HT11 32.45 29.28 
HT12 26.39 25.19 
HT13 25.44 26.11 
HT14 40.87 43.86 
HT15 8.97 8.91 
MEAN 23.64667 24.06467 
SD 9.172245 9.904852 
 
 Graph 7. Graphical representation of  Lung V20 results, showing the % of lung receiving 20 Gy 
or more with and without contrast 
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5.4.3 LUNG V30 
Table11. Lung V30 results, showing the % of lung receiving 30 Gy or more with and without 
contrast 
pt 
Lung V30 
Non-con 
% 
Con 
% 
HT01 10.72 10.42 
HT02 19.84 21.31 
HT03 17.67 18.44 
HT04 25.81 26.64 
HT05 14.84 14.88 
HT06 5.79 5.80 
HT07 17.78 17.92 
HT08 20.1 19.40 
HT09 13.47 13.51 
HT10 23.74 27.31 
HT11 28.17 25.39 
HT12 19.1 18.06 
HT13 21.34 22.05 
HT14 35.33 37.93 
HT15 6.33 6.31 
MEAN 18.66867 19.02 
SD 7.92866 8.45054 
 
Graph 8.  Graphical representation of Lung V30 results, showing the % of lung receiving 30 Gy 
or more with and without contrast 
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Hannah Thompson Page 56 
5.4.4 MEAN LUNG DOSE 
Table 12. Mean lung dose results with and without contrast  
pt 
MLD 
Non-con 
cGy 
Con 
cGy 
HT01 916 878 
HT02 1528 1633 
HT03 1315 1363 
HT04 1832 1879 
HT05 1128 1110 
HT06 511 513 
HT07 1344 1383 
HT08 1477 1426 
HT09 1289 1299 
HT10 1753 1956 
HT11 1947 1791 
HT12 1543 1473 
HT13 1539 1592 
HT14 2378 2505 
HT15 571 568 
MEAN 1404.733 1424.6 
SD 495.4909 524.2682 
 
Graph 9.  Graphical representation of Mean lung dose results with and without contrast  
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5.4.5 SPINAL CORD MAXIMUM DOSE 
 
Table 13. Maximum spinal cord dose results with and without contrast  
pt 
Spinal cord max 
Non-con 
cGy 
Con 
cGy 
HT01 2142 2095 
HT02 4302 4509 
HT03 5929 5917 
HT04 4169 4051 
HT05 1674 1567 
HT06 1349 1393 
HT07 3882 4046 
HT08 2615 2560 
HT09 3379 3189 
HT10 4383 4402 
HT11 3956 3995 
HT12 4481 4519 
HT13 2699 2730 
HT14 5059 5073 
HT15 2106 2173 
MEAN 3475.00 3481.27 
SD 1328.150325 1349.917 
 
Graph 10.). Graphical representation maximum spinal cord dose results with and without 
contrast 
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5.4.6 CONFORMITY INDEX 
Table 14. conformity index results with and without contrast  
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 11.  Graphical representation of Conformity index results with and without contrast 
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pt 
CI 
Non- 
con 
con 
HT01 1.35 1.39 
HT02 1.34 1.51 
HT03 1.56 1.55 
HT04 1.24 1.32 
HT05 0.74 0.62 
HT06 1.61 1.5 
HT07 1.18 1.14 
HT08 1.5 1.43 
HT09 1.33 1.29 
HT10 1.53 1.63 
HT11 1.55 1.65 
HT12 1.61 1.55 
HT13 1.4 1.42 
HT14 1.37 1.38 
HT15 1.66 1.63 
MEAN 1.398 1.400667 
SD 0.2318 0.257972 
P= 0.902765 
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5.4.7 HETEROGENEITY INDEX 
Table 15. Heterogeneity index results with and without contrast  
 
pt 
HI 
Non- 
con 
Con 
HT01 1.12 1.13 
HT02 1.11 1.11 
HT03 1.13 1.14 
HT04 1.08 1.08 
HT05 1.13 1.12 
HT06 1.12 1.12 
HT07 1.08 1.08 
HT08 1.14 1.14 
HT09 1.14 1.12 
HT10 1.11 1.11 
HT11 1.12 1.12 
HT12 1.09 1.09 
HT13 1.08 1.09 
HT14 1.16 1.11 
HT15 1.16 1.11 
MEAN 1.118 1.111333 
SD 0.02678 0.019223 
 
Graph 12.  Graphical representation of Heterogeneity index results with and without contrast  
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5.5 SUMMARY OF MAIN EXPERIMENT 
The experiment was conducted as planned, although subject numbers were less than 
anticipated. A total of 15 patients were available for analysis.  Measurement were recorded 
and reported as above.  No statistical differences were demonstrated between the plans 
produced on the contrast and non contrast CT data sets.  These results are discussed in 
chapter 6.  
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CHAPTER 6. DISCUSSION 
This section will attempt to interpret the results, discuss the limitations of the study and 
possible errors induced. Finally some recommendations are made for further study.  
The purpose of this study is to either validate or negate the current practice at the research 
centre of taking two CT scans, one with and one without the presence of contrast.   Previous 
research was reviewed and the validity of the reported results was doubted due to varying 
research methods, small study numbers and the anatomical sites studied.  
One would expect to see a systematic error as a result of the contrast presence, showing an 
increase in dose delivered on the non contrast scan compared to the dose calculated using 
the contrast enhanced CT scan.  This would be due to the assumption that the higher density 
contrast would absorb more radiation in the planning calculations, yet due to it not being 
present at the treatment delivery, there would be less absorption leading to increased dose 
delivered. This is not the case in these results. The results show differences in both 
directions and this seems to demonstrate a non systematic cause. The source of these 
possible random errors is discussed along with a discussion on the overall results.  
  
6.1 INTERPRETATION OF RESULTS 
The results show that there are no statistically significant differences between the plan 
optimising variables calculated on the pre- and post-IV contrast scans, hence it may not be 
necessary to account for the presence of IV contrast on the planning CT scan.  This supports 
the results of previous researchers in this area (Lees, et al., 2005, Shibamoto et al., 2007).  
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6.2 RESEARCH METHODS 
There was doubt around the results of previous research due to the methods employed by 
the researchers. This experiment was conducted in a more clinically relevant way, to assess 
the differences and potential error introduced by IV contrast being present in planning CT 
scans. This was modeled off the methods used by Choi (2006) and colleagues. The pre- and 
post-test experimental method meant that the plan optimising variables could be assessed 
on the same patient in the same positions, with and without the contrast present. Previous 
researchers have used various methods to recreate this situation, forcing REDs and using 
anthropomorphic phantoms (Lees et al., 2005, Liauw et al., 2005). This study used both pre 
and post IV contrast scans, placing the same plan on each, and analysed the differences. This 
method is more akin to the clinical situation where planning would be done on a contrast 
enhanced CT scan and treatment delivered to the patient with out contrast present.  The 
results of this study are therefore more valid due to the realistic testing environment.  
The current method employed in my department of using two scans, pre- and post-contrast, 
does introduce a number of errors however.  The two CT scans, although taken in the same 
treatment position, are taken in a ‘free breathing state’ and this results in images obtained 
in different phases of the breathing cycle. This difference makes accurate ‘fusing’ of the two 
scans difficult. The radiation oncologist then contours the gross tumour volume (GTV) and 
creates the clinical target volume/ planning target volumes (CTV/PTV) based on the contrast-
enhanced CT data set. This is the volume that the Radiation Oncologist  (RO) requires to be 
irradiated to achieve the aim of treatment (ICRU, 1999).  This could mean that the locations 
of these planning targets are not exactly the same on the non-contrast data set, which is 
used for planning, and its location in relation to the OAR is important when optimising 
radiation therapy.  This is especially evident with radical lung cases where the effect of 
Hannah Thompson Page 63 
physiological movement due to respiration and heartbeat is unavoidable without the use of 
expensive and complicated gated CT scanning and treatments.  
The errors induced due to these physiological changes between the two scans may account 
for some of the random errors in the results obtained. The results fluctuate between 
patients, some showing higher doses with contrast whilst other show higher doses without 
the contrast present.  
Miller and Joon (2002) attempted to use ‘breath hold’ CT scans to minimize the likelihood of 
movement between CT scans with and without contrast for their study.  This experimental 
method did not relate to the clinical situation in which treatment is delivered in a free 
breathing state. Miller and Joon found that the number of MUs needed to deliver the same 
dose to the PTV changed when contrast was present on a scan. Unfortunately the method of 
their experiment, in keeping the dose constant and changing the MUs, makes comparison 
with this research difficult.  
This research’s method of keeping the MUs constant between the two calculation sets was 
different to previous researchers; this was done to produce results that gave an accurate 
account for any potential miscalculations in dose delivered. Dose differences are more 
clinically relevant than MU changes.  Dose volume histograms were used to determine dose 
differences between plans. The variables used in this experiment are the most commonly 
used variables for assessing the optimisation of a thorax plan; V5, V20, V30, MLD, spinal cord 
maximum, CI and HI. This produced results which are clinically relevant. 
Another important difference in the research method used in this study is the planning 
technique. Previous studies have used very simple planning techniques and did not report 
the algorithm used in planning calculations. Ramm’s 2001 study used basic planning 
techniques utilising 2-4 fields. Modern planning techniques, as used in this study, often use 
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more beams than this. Ramm (2001) found that with an increase in beam numbers the 
effect of the contrast on dose calculations decrease.   This can also be supported by the fact 
that the studies using IMRT in the head and neck area, also found no statistical differences in 
dose calculations in the presence of contrast (Choi et al., 2006). It is likely those results could 
be due to the large number of beams utilised with IMRT.  This research utilized 
Superposition calculations algorithms for dose calculations which is the most up to date 
technology available at the research centre.  
 
6.3 SITE STUDIED 
A major difficulty when reviewing the literature was the sites studied when investigating the 
Impact of IV contrast on dose calculations. The majority of previous studies done have been 
done in the head and neck area (Choi et al., 2006; Liauw,et al., 2005). It was proposed that 
the thorax would be a site in which the contrast would have more of an effect on dose 
calculations. This was based on studies done by Ramm et al. (2001) who found that the 
larger the vessel was containing contrast, the larger the effect on dose calculations. The 
thorax contains much larger blood vessels and the heart which fill with contrast during a 
contrast enhanced CT scan.  The head and neck studies reviewed all showed that there was 
no influence due to the contrast present in the small blood vessels in the head and neck 
(Choi et al., 2006).  
 This prediction of a greater influence in the thorax planning scans was also supported by 
smaller studies in which upper abdominal areas showed some differences in the MUs 
required to be delivered to deliver the same dose in the absence of contrast when planned 
on contrast scans (Shibamoto et al., 2007).   These studies hypothesised that this increase in 
need for MUs in the presence of contrast was due to the larger organs such as liver and 
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kidneys up taking large amounts of IV contrast, this could also be similar to the heart and 
major blood vessels containing contrast. However the results of this study have not shown 
this.  
Additional problems with previous studies in which the impact of IV contrast was attempted 
to be investigated in the Thorax was the use of phantoms which could not clinically 
represent the true physiological intake of contrast in the thorax. This study addressed this 
issue by using real patient’s scans with and without contrast.  
 
6.4 RED-CT NUMBER CONVERSION FILES 
Reviewing the published literature on previous experiments in the area of the effect of 
contrast on dose calculations showed that the problem of CT-RED conversion of higher 
atomic number materials is often not considered. This study has considered this issue. 
The CT-RED experiments conducted were successful in demonstrating that the relationship 
between CT numbers and RED in higher atomic number substances is not linear. Current 
modeling should not be used when trying to relate high atomic material CT numbers to RED 
for planning purposes. The results show that the XiO planning system with its current CT-
RED conversion file will ‘cap’ the RED at 1.71 for all CT values higher than 1152, which is 
approximately the density of cortical bone.  Experiments done showed that with no 
correction for this fact, using a single beam at standard calibration conditions, contrast 
induced a measured error in the realms of 10-15%.  These results must be viewed with 
caution. This does demonstrate that when a single beam is passed through a volume of 
contrast, errors are possible, however in the clinical situation, only small amounts of 
contrast are present for the planning scan also beams are not usually directed straight 
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through the high uptake areas such as the heart and multiple beams are used, all of which 
reduce these errors significantly, as shown in the results of the main experiment.  
Initially there was concern that if the CT-RED conversion files were inaccurate, the results of 
the main experiment of this thesis would be invalid.  Upon further consideration of this 
situation, it is proposed that this is not of concern for this study.   With a capped RED 
conversion file the TPS will assign the maximum RED to any densities higher than the cap 
level, this would mean the TPS models the radiation interactions based on the maximum 
RED of 1.71 and not the actual RED of the contrast. This may mean the TPS is 
underestimating the absorption of the radiation by the contrast. If the case was that the 
contrast was present for the treatment, this would be a concern, however in this study the 
contrast is not actually present for the treatment hence any underestimation of absorption 
is not of concern.   
As this study has shown that the differences between the contrast and non contrast scans 
are not significant, then the fact that the modeling of the contrast in the TPS is not 
completely accurate is of no concern, because ultimately the differences between the 
calculations are not significant.  
This study used the capped RED file, and has shown that there is no statistical difference 
between the calculated dose in the presence of the contrast and the calculated dose without 
the contrast present.   As it is the current method to use a capped RED file and attempts to 
extend this were unsuccessful, the results from this study are still valid. Caution must be 
used if a non capped RED file is used to produce plans based on contrast scans, as this study 
has not compared the dose calculated using an extended RED file.  
 Previous published research does not discuss the use of capped RED files and hence it is 
difficult to relate their results.  CT-RED conversion files are an important consideration when 
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planning in contrast presence.  Personal investigation in to the CT –RED conversion files used 
by other departments has shown some departments simply extend their CT-RED file linearly. 
Experiments conducted in this study have shown that this is not accurate for higher atomic 
number materials. If calculations in the presence of contrast are done using this sort of file, 
errors are possible.   
 
6.5 CLINICAL APPLICATION 
The main conclusion of the experiment is that there is no difference between the two data 
sets, one prior to and one following the application of a ‘change’. These results have been 
obtained using the same set of circumstances and conditions, hence any differences seen, or 
not seen in this case, are valid.  
The results of this study support those of previous researchers in this area and other 
anatomical sites (Lees, et al., 2005, Shibamoto et al., 2007).  There is statistically no 
significance between the pre- and post-contrast scans results. This supports the actions of 
radiation therapy departments conducting only the one CT scan – with the presence of 
contrast and planning on this scan.  
 Hence there is no justification for the two scans to be taken. Taking two CT scans (with and 
without contrast) ultimately doubles the patient dose from imaging, following the ALARA 
principle radiation therapists are required to keep dose to patients to a minimum, taking 
unnecessary scans goes against this principle.  
Other possible sources of the random results shown, need to be considered. The studies 
subjects were of various sizes, with tumors in various locations in the thorax.  This variable 
could also be impacting on the results.  The use of larger subject numbers of more similar 
sites could reduce these errors.  
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6.6 LIMITATIONS OF THE STUDY 
There are a number of limitations to this study, the main one being in the contouring of the 
target volumes. The Radiation Oncologists contoured the targets onto the non-contrast 
scan, using the contrast scan to aid in this. The researcher then attempted to accurately 
reproduce this contouring on the contrast scan. Errors were introduced, as exact replication 
was not possible.  
A further limitation is the study numbers. Initially this study aimed to enroll 40 patients, 
however only 15 were successfully included in this study. A number of reasons account for 
this; firstly a reduction in the number of lung patients being treated radically in the 
department in which this study was conducted due to an increase in PET scanning as part of 
the diagnostic work up.  PET scanning has meant more patients are being deemed not 
suitable for radical treatment due to the presence of metastases that have previously gone 
undetected when using standard diagnostic techniques.  Secondly, the number of patients 
deemed ‘fit’ for IV contrast scans was less than expected. This is most probably due to the 
damaging effects of previous chemotherapy making patients unsuitable to receive contrast 
and also the poor performance status of many lung cancer patients. Lastly, one patient was 
excluded from the study as the aim of treatment changed to palliative after the scan and 
another was excluded as the contrast scan was not executed according to protocol and the 
volume of contrast administered was too small.   
6.7 RECOMMENDATIONS FOR FURTHER INVESTIGATION 
Areas for investigation include: 
 Further investigation using a larger patient cohort should provide more solid 
evidence that there is no significant difference between contrast and non-contrast 
scans.   
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 The impact on the production of Digitally Reconstructed Radiographs (DRRs) due to 
the presence of contrast. 
 The ability to use Megavoltage Cone Beam (MVCB) scans with contrast present to 
determine the true RED of the Contrast and the impact on dose calculations.  
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CHAPTER 7. CONCLUSION AND RECOMMENDATIONS 
 
This study has achieved its aims. It was intended to: 
1. Investigate the CT number – RED conversion for IV contrast 
2. Quantify any errors caused by the CT-RED conversion 
3. Make recommendations to the research centre, and other Radiation Therapy 
departments considering the use of IV contrast in radiation therapy planning of the 
thorax, on the optimal method for planning in the presence of IV contrast.  
 
The CT-RED number conversion investigation proved difficult but ultimately proved there is 
concern with simply extending RED conversion files linearly as many departments do. 
Investigations to quantify the possible degree of error showed with a single beam this could 
be in the realms of 10-15%, but based on other research this potential error should be less 
due to the beam numbers used in modern treatment techniques. 
The results show there is no statistically significant difference between the two plans with or 
without the IV contrast present. 
Recommendations can be made that only one planning CT scan needs to be taken, and that 
the presence of IV contrast on that scan will not influence the dose calculations significantly.  
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1. PURPOSE 
 
To provide a guideline for the administration of contrast agents for the 
purposes of radiation therapy planning. 
 
 
2. SCOPE 
 
Radiation Oncologists (RO) 
Radiation Oncology Registrars (ROR) 
Radiation Therapists (RT) 
Radiation Oncology Nurses (RON) 
Radiation Oncology Booking Clerk 
 
 
3. PROTOCOL INDEX 
 
 
 SUBJECT 
A Administration of Contrast – clinical guideline 
B Contra-indications for IV contrast media in 
radiation oncology 
C 4.  
Reactions to Contrast media, treatment and 
DOCUMENTATION 
D Treatment for extravasation of contrast media 
E Storage and warming of contrast media in 
radiation oncology 
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A. Administration of Contrast – clinical guideline 
 
A.1 ROLES & RESPONSIBILITIES 
 
Radiation Oncologists 
 The RO will append the QCL to alert the Booking Clerk that the patient will 
require contrast at CT.  
 The RO will give the patient a blood test request form to check the serum 
creatine levels and instruct the patient that once they have been informed of 
the appointment time for the CT they are to have the blood test done 2 days 
prior to the appointment. 
 A RO or ROR prescribes the contrast to be administered. 
 
Radiation Oncology Registrars (ROR) 
 A ROR must be present in the CT/Planning area and aware that the 
contrast is to be given before intravenous contrast is administered. 
 A RO or ROR prescribes the contrast to be administered. 
 The RORs complete and maintain the level 7 CORE training. 
 The ROR is responsible for Patient consent process 
 
Radiation Therapists (RT) 
 Complete Fundamental IV Therapy training and injector training. 
 Fundamental IV Therapy training & Use of the AED+ defibrillator will be 
part of CORE skills, a bi-annual requirement for all Radiation oncology 
staff.  Injector training will be given initially to all staff then the CT 
supervisor will be responsible to provide continuing education for current 
and new staff to the area. 
 The RT ensures that the consent form for contrast injection is complete and 
signed prior to commencing the contrast scan. 
 
Radiation Oncology Nurses (RON) 
 Commence Intravenous Fluids prior to contrast to ensure the IV peripheral 
cannula remains patent until the patient leave nursing clinic area. 
 
Booking Clerk 
 The booking clerk will send the “Consent form for X-Ray Contrast 
Injections” and “Information sheet for patients receiving contrast media” to 
the patient with their appointment time. 
 The booking clerk will book the CT scan on Wednesday afternoons only. 
 Patients requiring a mask will have their mask made prior to the nurse‟s 
appointment.  It is possible that this may be in the morning if necessary to 
allow for more bookings Wednesday afternoons.  
 
A.2 PREREQUISITES 
 
 Consent form and drug chart have been completed and signed. 
 The RON will retrieve the blood test results for patients receiving a contrast 
scan prior to the CT scan. 
 The patients blood test results have been checked by the ROR as part of the 
initial patient assessment prior to the CT appointment and levels of Serum 
Creatinine are within limits (consider using Visipaque 270 if levels are 
high). 
 Suitable Intravenous access. 
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 Contrast is warmed in the incubator to a temperature of 37°. 
 Emergency resuscitation trolley and AED (automatic external defibrillator) 
is present in room. 
A.3 CLINICAL GUIDELINE 
 
STAFF HEALTH AND SAFETY  
 
 All Staff involved have the appropriate level of training. 
 Resuscitation equipment and emergency trolley are present 
throughout the procedure. 
 Infection control standards are maintained. 
 No persons remain in the CT room, other than the patient, during 
the scan. 
 
Assessment Prior to CT 
 Prior to the CT appointment, in a clinic room, the ROR will go over the 
consent form for x-ray contrast injections, and if contrast is recommended, 
it will be signed by the patient and the ROR (as a witness). 
 If the patient is requiring a mask the mask can be made prior to the 
insertion of the cannula. Once the mask is made the patient can be sent 
around to the nurses for the cannulation and pre contrast interview with the 
ROR.  
 
Preparation Prior to CT 
 Take a gown to the nurses clinic so the patient can change before the line is 
inserted. 
 The ROR will fill out the Drug chart to prescribe the contrast and IV fluids as 
well as establish suitable IV access. 
 The RON will commence a 0.9% Sodium Chloride infusion (250ml bag) to 
ensure IV Cannula is patent and fluids are running freely.   
 The patient will then be transferred to the CT room, and the procedure 
explained to them. 
 RT liaises with ROR re the size of the cannula inserted. If a 20 gauge is used 
flow rate 3ml\sec and if a 24 gauge cannula is used reduce flow rate to 
1ml/sec.  
 The RT takes the pre warmed (37°) contrast  out of the incubator and checks 
the expiry date and type/strength of contrast with another RT.  
 The two RTs who checked the contrast will sign the drug chart under „nurse‟s 
signature‟ and attach the contrast batch label to the patients drug chart. 
 The required contrast will be drawn up/loaded in to injector by the RT and 
checked by the ROR prior to aseptically disconnecting the IV 0.9% Sodium 
Chloride infusion, attaching a combi lock to the IV administration set and 
connecting the automatic injector to the patient. 
 The appropriate scan protocol will be selected; this will include a topogram, a 
scan with out contrast, followed by the administration of the contrast, a time 
delay (if necessary) and a second scan of the same area. 
 After the first, non-contrast CT scan the CT mark will be placed and then 
marked on to the patient with gentian pen. Remind the patient to remain very 
still through out this procedure. With-out re-zeroing the couch move the 
patient back to the start position. 
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Contrast Administration 
 The contrast will then be administered while the appropriately trained staff 
member observes the injection site, watching for signs of extravasation (see 
appendix D).  The site needs to be observed for 10-15 seconds then the staff 
member will leave the room and start the second CT scan after the 
appropriate time delay. 
 Consider using a slower flow rate of 1ml/sec for elderly or frail patients. 
 
 
 
 
 
 
 
 
Completion of CT 
 Once the final CT scan is complete and all final marking/photographs and 
measurements are done the injector can be disconnected and patient 
assisted off the couch.  
 The IV 0.9% Sodium Chloride infusion can be restarted: wash hands,  
scrub the hub with an alcohol wipe and allow to air dry, remove the 
combi lock and re-connect the IV administration tubing and commence 
the infusion by opening the roller clamp. 
 The patient should then remain in their gown and pre treatment patient 
education can be given.   
 The patient should be observed for 30 minutes after the administration of 
the contrast, once the 30 minutes is up the IV cannula can be removed by 
the RT.  
 The patient should be advised of possible late side effects of the contrast 
and, to drink plenty of water over the next 24 hours.  
SITE Recommended 
contrast agent 
Recommended 
amount of 
contrast 
Recommended 
flow rate 
Recommended 
time delay 
Radical 
Brain 
Omnipaque 350 50 ml  Hand pushed None (up to 5 
minutes is 
acceptable) 
Radical 
Chest, 
Head & 
Neck, 
Seminoma, 
Pelvis 
Omnipaque 350 100 ml 2ml/sec (in back 
of hand, if using 
cannula in ante 
cubital fossa use 
3ml/sec) 
30-40 seconds 
Hannah Thompson Page 84 
 
B. Contra-indications for IV contrast media in 
radiation oncology 
 
B.1 ROLES & RESPONSIBILITIES 
 
The RO / ROR is responsible for the decision to use contrast media and which 
contrast media to be used.  
 
B.2 PREREQUISITES 
 
Patient to complete the pre- contrast consent form and be interviewed prior to 
administration of contrast.  
 
B.3 GUIDELINE 
 
At the initial consultation patients who may be requiring a contrast scan are to 
be given a blood test request form for serum creatine levels and instructed that 
they are to have the blood test done two days before they come for the radiation 
therapy planning CT. 
The booking clerk will remind the patient about having the blood test two days 
before the CT appointment when the patient is given their appointment time.  
A „contrast information and consent‟ form is sent out with their initial 
appointment time. 
The day prior to the CT appointment, the RON will obtain the patient‟s blood 
test results for serum creatinine levels and inform the ROR.  
The ROR will go over the consent form at the pre CT appointment in the clinic 
rooms.  
The ROR will assess the patient‟s suitability for IV contrast and decide if 
Omnipaque 350 or Visipaque 270 will be used.  
Any patient taking Metformin will not have IV contrast.  
The Patient, if happy to proceed with the scan, the ROR or RO will complete the 
consent process.  
 
Conditions which MUST be brought to the attention and assessed by 
the Radiation Oncologist or Registrar prior to administration of IV 
contrast media 
 
History of previous reaction to any contrast media 
Asthma 
Allergies  
Multiple Myeloma 
Diabetes (especially if taking Metformin)  
Renal Dysfunction 
Cardiac disease 
Pulmonary hypertension 
Epilepsy or history of seizures 
High serum creatinine levels (see Table 1) 
Pregnancy/breast feeding 
Phechromocytoma 
Hyperthyroidism 
Waldenstroms macroglobulinanaemia 
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The RO or ROR will decide which contrast media to use and whether to go 
ahead with the contrast injection or not. 
 
Table 1 Serum Creatinine levels: 
 
Serum 
Creatinine 
level: 
Result: Contrast: 
<130 normal Omnipaque 350 
130-180 Abnormal  Review need for contrast. If necessary use 
Visipaque 270. Patient may also require 
additional fluids prior and after 
administration of contrast.  
>180 Very 
High 
Not recommended 
 
Reactions to Contrast media, treatment and 
documentation 
 
C.1 ROLES & RESPONSIBILITIES 
 
Reaction & Treatment 
Staff present at the procedure Observation of patients given contrast. 
Informing the Radiation Oncologist/Registrar 
of any  
adverse reactions. 
Resuscitation, emergency first aid. 
Dialling 777 in an emergency to call Arrest team. 
Patient monitoring. 
 
Radiation Oncology Nurses Maintenance of Arrest trolley. 
Resuscitation, emergency first aid. 
Patient monitoring. 
 
Radiation Registrar  Deciding on treatment options. 
Resuscitation, emergency first aid. 
Administration of IV medication. 
Referral to E.D. if necessary. 
 
 
Documentation 
Radiation Registrar   Fills in required MCH documentation (adverse 
reaction to   
Medicine)                       
 
Radiation therapists  Ensure reaction is recorded in LANTIS  in the 
Patient notes and    in  “Allergy and Alerts”  
 
C.2 PREREQUISITES 
 
Patient with adverse reaction to Intravenous or other contrast 
Emergency drugs and equipment available 
Oxygen supply 
IV access 
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ALLERGY stickers – Nurses office 
“ALERT NOTIFICATION FORM”  
“Suspected Adverse Reaction Form”  
 
C.3 CLINICAL GUIDELINE 
 
Health and Safety 
 
Standard precautions for IV Injections and care with bodily fluids 
Ensure a Radiation Oncologist/Registrar is available and aware of the 
injection before administering contrast 
 
 
REACTION & TREATMENT 
 
Minor Reactions 
Flushing, nausea, arm pain, pruritis, vomiting, headache, mild urticaria. 
These are usually mild and self-limiting and require no specific treatment other 
than reassurance. 
 
Oral Claratyne (Loratadine) 10mg may be given  
or Phenergan (Promethazine) 25mg im or IV(diluted in 10ml saline) 
 
Bronchospasm 
Mild to moderate bronchospasm can be treated with Salbutamol inhalation 
Hydrocortisone 
100mg iv 
For more severe bronchospasm add Adrenaline (5ml of 1/10,000 im) until 
response achieved. 
 
Reassurance of the patient and Oxygen via high concentration mask 
administration are also important 
 
Severe or life-threatening reactions 
Severe degrees of the above, convulsions, hypotension, unconsciousness, 
laryngeal oedema,  pulmonary oedema, severe cardiac arrhythmias or cardiac 
arrest.  
 
If there is felt to be any risk to the airway or cardiac output then the Cardiac 
Arrest team 777 should be called immediately. 
 
The following may be required: 
Adrenaline 1/10,000 1ml boluses IV or 5ml IM 
 Secure the airway with oral airway or ET tube 
Oxygen 
Artificial ventilation with Ambubag 
External Cardiac Massage 
Escalating doses of adrenaline if cardiac arrest 
Intravenous 0.9% Sodium Chloride 250ml, or  1000ml bags for infusion 
Frusemide (40-80mg IV) for pulmonary oedema 
Diazepam 10mg IV for convulsions 
Hydrocortisone 100mg IV for allergic  or anaphylactic symptom 
Phenergan (Promethazine) 25mg im or IV(diluted in 10ml saline) 
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C.4 DOCUMENTATION 
 
RT and RO or ROR 
  ensures LANTIS records are updated to include “ALLERGY 
and ALERT” 
  collects 4 forms for Radiation Registrar to fill in 
  sends forms to appropriate areas as indicated on forms  
    1.forms to Pharmacy 
   2.form to Medical records for patient notes 
   3.places “ALLERGIC” stickers in patients notes 
   4.Inform radiology of reaction 
 
ROR  - fills out 4 forms, gives forms to RT 
 
C.5 REFERENCES 
 
Complications in Diagnostic Radiology.  G.Ansell et.al. 3rd Edition  1996 
Blackwell Science 
Diagnostic Radiology  Grainger & Allison 2nd Edition 1992 Churchill 
Livingstone 
 
 
Treatment for extravasation of contrast media  
 
D.1 ROLES & RESPONSIBILITIES 
 
RTs involved in administration of intravenous contrast media are responsible 
for observation of IV site during injection of contrast media. 
RO/ROR/RT recognises signs and symptoms of extravasation and discontinues 
infusion or injection immediately. 
Radiation therapy staff provides immediate first aid. 
Radiation therapy staff document incident in the patient notes in LANTIS and 
inform nurses in ward if an inpatient. 
 
D.2 PREREQUISITES 
 
Appropriate consent form for CT scan which requires administration of 
intravenous contrast media. 
Insertion of intravenous cannula into identified and prepared patient. 
RT‟s who are qualified to administer intravenous contrast medium. 
 
D.3 PROCEDURE 
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Health and Safety 
Extravasation will be avoided by careful attention to technique. 
If an incident of extravasation occurs it will be treated promptly in 
accordance with procedure. 
 
 Infusion is discontinued immediately and I.V. cannula removed. 
 
 Apply ice pack to affected area. 
 
 
 Elevate affected limb. 
 
 Explain what has occurred to the patient and reassure as necessary. 
 
 
 Inform RO in charge of patient. 
 
 Inform ward staff when patient is an inpatient. 
 
 
 Document incident in patient notes on LANTIS. 
 
 The Radiation Oncologist will decide if the scan is to be continued, or the 
patient rebooked. 
 
 
 Arrange follow-up if required. 
 
D.4 DEFINITION 
 
Extravasation is defined as escape of vesicant fluid from its proper vessel into 
the surrounding tissues (Dorland). 
 
Signs and Symptoms 
 
Erythema 
Swelling usually subside without further untoward side effects 
Burning or stinging sensation 
 
Patients at Risk 
 
Elderly (fragile veins) 
Unconscious patients 
Past radiation to I.V. site 
Peripheral vascular disease 
Diabetes Mellitus 
Raynauds disease 
 
D.5 REFERENCES 
 
Radiology Journal (76:69-70, 1991) 
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Dorlands Pocket Medical Dictionary 21st Edition 
Hannah Thompson Page 90 
Storage and warming of contrast media in radiation 
oncology 
 
E.1 ROLES & RESPONSIBILITIES 
 
Radiation therapy staff working in CT will ensure that the bottles of contrast 
stored in the incubator are not kept for longer than 3 months at 37◦C or past 
their expiry date. 
 
RTs administering the IV contrast will ensure the contrast is warmed to 37◦C 
prior to injecting. 
 
The Specialist/supervisor working in CT will ensure that daily QA of the 
incubator is performed by all staff. 
 
E.2 PREREQUISITES 
 
Contrast media 
Light tight Incubator set to 37◦C 
 
E.3 CLINICAL GUIDELINE 
 
STAFF HEALTH AND SAFETY 
 
Check setting on the incubator – must be 
37◦ C (body temperature) 
Glass bottles of contrast media may be 
stored for up to 3 months at 37◦ C 
Contrast media should be protected from 
light and secondary x-rays 
 
Staff in CT can collect the required contrast media (Omnipaque 350) from the 
cupboard in clean utility, where it is ordered on Imprest.   (Visipaque 270 can 
be borrowed if needed from Radiology) 
The contrast is placed in the incubator with the date which is it was placed in 
the incubator written on a sticker and placed on the top of the bottle. 
Up to 6 bottles of contrast media are to be kept in the incubator at all times, 
when selecting a bottle for use ensure you take the bottle with the oldest date 
(not older than 3 months). 
Always check the contrast media‟s expiry date prior to use. 
 
QA of contrast media warming incubator: 
 
The incubator is stored in the store room in the CT room.  It is important that 
this be NOT stored in the actual CT room so to protect the contrast from 
secondary X-rays.  
 
Each day as part of the normal CT QA process the internal temperature of the 
incubator must be checked.  To do this, place a thermometer in the incubator 
Hannah Thompson Page 91 
for 5 minutes (with the door closed).  Read the temperature and record this in 
LANTIS under patient: CT QA, Assessments, daily RT QA. Tolerance for the 
temperature is ±2◦C of 37◦C . Report any out of tolerance readings to CT 
supervisor/specialist.  
 
E.4 REFERENCES 
 
Omnipaque information sheet 
Radiology storage of contrast media documentation 
 
 
 
5. DEFINITION 
 
AED+ – Automatic external defibrillator 
RO – Radiation Oncologist 
RT - Radiation therapist 
IV – Intravenous  
 
 
6. FURTHER INFORMATION / ASSISTANCE 
 
Resuscitation officer 
ICU staff 
Radiation Oncologist 
Radiation Oncology Staff Nurse 
Pharmacist 
 
 
7. RELATED MDHB DOCUMENTS 
 
MDHB-3726 Information & Consent Form for X-ray Contrast Injections 
[Form] 
MDHB-1002 Adult peripheral intravenous cannulation [Procedure] 
 
Intravenous Contrast for Radiation Therapy Planning CT Scanning – Patient 
information sheet 
 
 
8. KEYWORDS 
 
Contrast media, Radiation therapy, CT scanning, Extravasation, Incubator QA 
 
 
